Dr. Tison speaks at the Future of Individualized Medicine 2019.
Using Artificial Intelligence to Expand what is Possible in Medicine | UCSF Cardiology Grand Rounds 2022
Dr. Tison co-chairs the National Institutes of Health Heart Lung Blood Institute Workshop on Artificial Intelligence for Clinical Decision Support, September 2025. Watch the recording for Day 1, Day 2.
The Tison lab receives the New Innovator Award from the National Institutes of Health Office of the Director for exceptionally creative, innovative and high impact research.
Four Ways Artificial Intelligence is Poised to Transform Medicine, UCSF Research Highlight 2024
Dr. Tison speaks at the Lawrence Livermore National Laboratory, Data Science Institute.
The San Francisco Chronicle discusses AI work from the Tison lab and efforts to translate these advances to improve patient care. August 2023.
Using AI to Automatically Assess Cardiac Systolic (Pump) Function from Routine Coronary Angiograms. JAMA Cardiology 2023. In Medscape, Science Magazine, AAAS, CardiacWire, MedImaging, Technology.org, UCSF, MedicalXpress, Healio, Physicians Weekly, Cardiac Rhythm News, AZORobotics, MDEdge, Cardiovascular Business, UCSF News, Cardiovascular News, the Limbic, Ma Clinique (French), News Medical, Mirage, Two Minute Medicine and others.
Worldwide Physical Activity Trends in the 2 years since COVID pandemic onset in The Lancet Global Health. In Runners World, Helio, Health Day, Newswise, News Medical, Doctors Lounge, Gazette-Times and others.
Dr. Tison talks to NPR about worldwide activity trends since the start of COVID-19 radio segment and article. March 2022.
Using AI-enhanced ECGs to assess longitudinal trends in disease status and drug treatment response in hypertrophic cardiomyopathy a Tison Lab study in JACC: Journal of the American College of Cardiology In Cardiology Today/Helio, Cathlab Digest, Medical News, UK News, Newswise, Newsbreezer South Africa, UCSF News. March 2022.
A Nature Reviews Endocrinology article highlights work led by the Tison Lab published in Nature Medicine detecting diabetes with smartphones, discussing the broad potential benefits of its accessibility and some of the work ahead to deploy this biomarker clinically. October 2020.
Using Deep Learning to Develop a Digital Biomarker for Diabetes from Smartphone-based Vascular Signals, a study in Nature Medicine led by the Tison lab. In AAAS, Medscape, The Wall Street Journal, STAT News, MobiHealthNews, Medgadget, Engadget (Japan), AI News, Cardiovascular Business, Diabetes News, Times Select (S. Africa), Freethink, Photonics, Interesting Engineering, New Atlas, Wonderful Engineering, Medical News, Tech and Geek, Mental Daily, Web 24 News, MedIndia, Bioon (Chinese), Daily Geek (French), NCYT (Spanish), Sputnik (Arabic), BECTN (Russian), RTBF (Belgium), Sputnik (Japan), MedicinaSA (Brazil), UCSF News and Medical Xpress. August 2020.
Worldwide Effect of COVID-19 on Physical Activity and Implications for Social Distancing, a study in the Annals of Internal Medicine led by the Tison lab. In The New York Times (Article 1, Article 2, and Article 3), The Washington Post, The Atlantic, National Public Radio (NPR), Vox, World Economic Forum, MedPage Today, AAAS, UCSF News, Becker's Hospital Review, Science Codex, Inquisitr, KXLH, The Irish Times, The Brisbane Times, The Sydney Morning Herald, The Borneo Bulletin, The Age, WA Today, Teens in Health, The Times of India, and an ABC News Segment. July 2020.
*Please refer to the primary article for scientifically appropriate data interpretations and conclusions. Any interpretations or connotations beyond these, such as reflected in this or any news article, may not reflect the intended message or opinions of the Tison lab.